Article
Featured Articles
Read our latest stories on the people and scientific innovations making a difference in patients’ lives.
Some older people living with cancer aim for remission but lack needed resources to help make treatment decisions, global survey reveals
Every year, World Cancer Day, an initiative led by the Union for International Cancer Control, is about taking action. The theme, “I Am and I Will,” charges us as a cancer community to rally together and better serve those living with the disease and their support systems. At Pfizer, one way we’ve been supporting the community is by helping to eliminate barriers to optimal care, particularly for those over the age of 65, who research has shown may not always receive the best care available.1,2,3...
Are You at Risk for a Blood Clot?
NBC News war correspondent David Bloom was the image of health. In 2003, he was a 39-year-old avid tennis player. His work brought him to Iraq, where he was embedded with the 3rd Infantry Division, advancing toward Bagdad. Ultimately, it wasn’t the war, but a blood clot that killed Bloom, according to a TODAY.com account of his death.1One night, he went to sleep out under the stars on a tank fender. He called his wife, Melanie, and mentioned that he had leg cramps. The symptom appeared natural...
Eczema vs. Psoriasis: What’s Causing My Itchy Skin?
Getting patches of red and itchy skin that may come and go could have you wondering: Is it eczema or psoriasis, and what’s the difference? Eczema and psoriasis are two distinct skin diseases that may require different treatment plans.1Although they may be difficult to tell apart, a dermatologist (a doctor who specializes in skin conditions) can spot the differences between these two non-contagious and common skin conditions. That’s why it’s important to speak to your healthcare provider to get...
Albert Bourla On Ensuring Equitable Access to COVID-19 Vaccines
We have crossed another milestone in the fight against COVID-19. I am proud to announce that Pfizer and BioNTech have signed an advanced purchase agreement with COVAX for up to 40 million doses of our COVID-19 vaccine in 2021, subject to the execution of additional agreements under the COVAX structure. Since the very beginning of our vaccine development program, Pfizer and BioNTech have been firmly committed to equitable and affordable access of COVID-19 vaccines for people around the world...
Can You Inherit Rheumatoid Arthritis? Genetic vs Hereditary
Inflammation that leads to pain, swelling, stiffness, fatigue, and loss of joint function, are a fact of life for more than one million people in the United States who live with rheumatoid arthritis (RA).1 The chronic autoimmune disease causes the immune system to attack the healthy tissues surrounding the joints; it mainly affects the wrists, hands and knees (and often attacks numerous joints at once).2Is rheumatoid arthritis genetic? In addition to risk factors such as age, sex, smoking and...
Biologics vs. Biosimilars: Understanding the Difference
Maybe you’ve heard of biologics and biosimilars. You might even be taking biological or biosimilar medicines to treat cancer, rheumatoid arthritis, ulcerative colitis, psoriasis, or other health conditions. Still, maybe you have questions about what the differences and similarities are or how these drugs are developed.Biologics revolutionized the prevention, treatment, and outlook of many serious diseases. Now, biosimilar advancements in these drugs are helping to provide expanded access to...
Distributing Our COVID-19 Vaccine to the World
An Open Letter from Pfizer Chairman and CEO Dr. Albert Bourla Every day, I am asked about how Pfizer and our partners at BioNTech will distribute our COVID-19 vaccine now that it has begun to be authorized by regulators in different countries. People have questions about the process, the storage logistics and everything in between. But the underlying question is always the same: How will Pfizer and BioNTech ensure a seamless distribution of our vaccine? More than 70 million cases of COVID-19...
Celebrating Our Veterans: A Salute to Their Service
It takes great bravery and honor to serve in the U.S. Military. At Pfizer, we are thankful to all veterans for their patriotism, their selflessness and their sacrifice. And, we are proud to call many men and women who have served in the armed forces Pfizer colleagues. We salute their service and invite you to read their stories. Chris McQueen, Pfizer Facility Maintenance Supervisor, Rocky Mount, North CarolinaI served in the United States Navy as a Gas Turbine System Technician Mechanic...
Cancer Biomarkers: Paving the Way for Better Lung Cancer Treatment
Receiving a lung cancer diagnosis may inspire a lot of questions: Will my cancer spread? What are the best treatment options for my type of lung cancer? How well do treatments work?There are no one-size-fits-all answers to questions about lung cancer—and that can be a good thing. Scientific advances have led to the practice of “precision medicine” or treatments tailored to patients based on the genes and proteins found in their tumor. In cancer treatment, it involves looking at changes in the...
An Open Letter from Pfizer Chairman and CEO Albert Bourla
As we get closer to an important data readout from our COVID-19 vaccine program, I wanted to speak directly to the billions of people, millions of businesses and hundreds of governments around the world that are investing their hopes in a safe and effective COVID-19 vaccine to overcome this pandemic. I know there is a great deal of confusion regarding exactly what it will take to ensure its development and approval, and given the critical public health considerations and the importance of...
COVID-19 Vaccine Maker Pledge
The CEOs of AstraZeneca, BioNTech, GlaxoSmithKline, Johnson & Johnson, Merck, Moderna, Novavax, Pfizer, and Sanofi, have made a historic pledge to the world, outlining a united commitment to uphold the integrity of the scientific process as they work towards potential regulatory filings and approvals of the first COVID-19 vaccines. All nine CEOs signed the following pledge: We, the undersigned biopharmaceutical companies, want to make clear our on-going commitment to developing and testing...
Improving Access to Cures Through Innovation
Patients deserve affordable access to the best healthcare possible. That’s why Pfizer invests in research and development: to produce groundbreaking treatments, like the COVID-19 vaccine, that improve people’s lives. It’s this investment in innovation that enables our scientists to make dramatic strides in healthcare. Their work advances life-changing therapies for the millions of patients we serve.To help even more patients access the medications they depend on, we need smart public policies...
Media Resources & Contact Information
Anyone may view our press releases, press statements, and press kits. However, to ensure that customers, investors, and others receive the appropriate attention, Pfizer Media Contacts may only respond to calls and emails from professional journalists.